Back
Zai Lab Ltd (ZAILF) Price
ZAILF Stock Price Chart
ZAILF Earnings
Zai Lab Ltd
$0
0%
$0
At close: Jan 22, 16:00:00 GMT-5
$0
0%
$0
Post-market: Jan 22, 20:00:00 GMT-5
Latest Earnings Results: Q3 '25
Reported: 2025-11-06
Historical Earnings
Quarterly
Annual
EPS
Revenue
Earnings FAQ
How did ZAILF's recent EPS compare to expectations?
How did Zai Lab Ltd ZAILF's revenue perform in the last quarter?
What is the revenue estimate for Zai Lab Ltd?
What's the earning quality score for Zai Lab Ltd?
When does Zai Lab Ltd report earnings?
What are Zai Lab Ltd's expected earnings?
Did Zai Lab Ltd beat earnings expectations?
Key Stats
Prev.Close
--
Open
--
Day's Range
-
52 week range
-
Volume
--
Avg.Volume
--
EPS (TTM)
--
Dividend yield
--
Market Cap
--
What is ZAILF?
Zai Lab Ltd. is a biopharmaceutical company, which engages in the developing and commercializing therapies that address medical conditions with unmet needs in oncology, autoimmune disorders, infectious diseases, and neuroscience. The company is headquartered in Shanghai, Shanghai. The company went IPO on 2020-09-28. The firm is focused on discovering, developing, and commercializing products that address medical conditions with significant unmet needs in the areas of oncology, immunology, neuroscience, and infectious disease. The firm has a series of patented drug candidates from the discovery stage to the late clinical project, including ZEJULA, OPTUNE, QINLOCK, NUZYRA and VYVGART, and others. The firm conducts its businesses within domestic and overseas markets.
Features
Trading Strategies
Resources
© 2025 Finture Development Limited. All rights reserved